Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapeutic equivalence of Epoetin STADA versus reference epoetin
2007-002984-28Phase 3Completed
- Sponsor
- STADA Arzneimittel AG
- Start
- Feb 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial of epoetin zeta in Uraemic Anaemia (2 arms), sponsored by STADA Arzneimittel AG. Primary endpoint: Mean haemoglobin level during the last 4 weeks of treatment. Started Feb 2008; status: completed.
02
Drugs
epoetin zeta
03
Conditions
Uraemic Anaemia
Beyond the preview
Go deeper on 2007-002984-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002984-28.